Estabrook Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49K | Buy |
16
+2
| +14% | +$811 | ﹤0.01% | 286 |
|
|
2025
Q1 | $6.97K | Buy |
14
+2
| +17% | +$995 | ﹤0.01% | 273 |
|
|
2024
Q4 | $6.24K | Hold |
12
| – | – | ﹤0.01% | 291 |
|
|
2024
Q3 | $7.42K | Hold |
12
| – | – | ﹤0.01% | 294 |
|
|
2024
Q2 | $6.64K | Buy |
12
+1
| +9% | +$553 | ﹤0.01% | 292 |
|
|
2024
Q1 | $6.39K | Buy |
11
+1
| +10% | +$581 | ﹤0.01% | 298 |
|
|
2023
Q4 | $5.31K | Hold |
10
| – | – | ﹤0.01% | 309 |
|
|
2023
Q3 | $5.06K | Hold |
10
| – | – | ﹤0.01% | 312 |
|
|
2023
Q2 | $5.22K | Hold |
10
| – | – | ﹤0.01% | 320 |
|
|
2023
Q1 | $5.76K | Hold |
10
| – | – | ﹤0.01% | 327 |
|
|
2022
Q4 | $5.51K | Hold |
10
| – | – | ﹤0.01% | 334 |
|
|
2022
Q3 | $5.07K | Hold |
10
| – | – | ﹤0.01% | 331 |
|
|
2022
Q2 | $5.43K | Hold |
10
| – | – | ﹤0.01% | 350 |
|
|
2022
Q1 | $5.91K | Hold |
10
| – | – | ﹤0.01% | 346 |
|
|
2021
Q4 | $6.67K | Hold |
10
| – | – | ﹤0.01% | 355 |
|
|
2021
Q3 | $5.71K | Hold |
10
| – | – | ﹤0.01% | 286 |
|
|
2021
Q2 | $5.05K | Buy |
+10
| New | +$5.05K | ﹤0.01% | 288 |
|
|
2013
Q4 | – | Sell |
-100
| Closed | -$9.22K | – | 480 |
|
|
2013
Q3 | $9.22K | Hold |
100
| – | – | ﹤0.01% | 392 |
|
|
2013
Q2 | $8.46K | Buy |
+100
| New | +$8.46K | ﹤0.01% | 398 |
|